ABCL
Ticker
AbCellera Biologics Inc
Company
Lifesciences
Industry
Healthcare
Sector
Financial Ratio Analysis
2018
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
+
2026
TTM
Revenue Growth YoY
β€”31.5%1907.9%60.9%29.4%-92.2%-24.2%160.6%β€”101.3%
Revenue Growth QoQ
β€”31.5%1907.9%60.9%29.4%-92.2%-24.2%160.6%β€”β€”
Gross Margin
100.0%100.0%88.4%87.9%86.3%100.0%100.0%100.0%β€”100.0%
EBITDA Margin
-8.5%-35.5%66.9%54.5%44.6%-623.8%-1091.7%-289.0%β€”-340.2%
Operating Margin
-8.5%-35.5%66.9%54.5%44.6%-623.8%-1091.7%-289.0%β€”-340.2%
Profit Margin
3.5%-19.0%51.0%40.9%32.7%-385.0%-564.8%-194.9%β€”-248.8%
FCF / EBITDA
0%0%0%0%0%0%0%0%β€”0%